中国血液净化 ›› 2013, Vol. 12 ›› Issue (02): 74-77.doi: 10.3969/j.issn.1671-4091.2013.02.00

• 临床研究 • 上一篇    下一篇

降钙素原在血液透析患者导管相关性血行感染中的应用价值

王芳   

  1. 福建省宁德市医院肾内科
  • 收稿日期:2012-06-04 修回日期:2012-12-13 出版日期:2013-02-12 发布日期:2013-02-12
  • 通讯作者: 王芳 573906900@qq.com E-mail:573906900@qq.com

The value of Procalcitonin for Catheter related bloodstream infection in Hemodialysis Patients

  • Received:2012-06-04 Revised:2012-12-13 Online:2013-02-12 Published:2013-02-12

摘要: 目的:研究降钙素原(PCT)在血液透析患者导管相关性血行感染(CRBSI)中的应用价值。方法:62例怀疑导管相关性血行感染的血液透析患者,采集血常规、C反应蛋白(CRP)、降钙素原血样后拔除导管,同时留取血培养及导管标本。结果:CRBSI组和非CRBSI组拔管时的血清PCT水平分别为7.16±5.84μg/L和0.97±1.44μg/L(P<0.001),而血白细胞计数(WBC)值及CRP值则无明显差别。结论:PCT在早期诊断CRBSI方面具有较高的临床价值。

关键词: 降钙素原, 血液透析, 导管相关性血行感染

Abstract: Objective: To study the value of procalcitonin for catheter related bloodstream(CRBSI)infection in hemodialysis patients. Methods: Blood samples of 62 hemodialysis patients who suspected catheter related bloodstream infection were obtained for procalcitonin level、c-reactive protein level、hemoculture and blood routine examination, catheter were also obtained for culture. Results: The procalcitonin level of Patients with CRBSI and without CRBSI were 7.16±5.84μg/L and 0.97±1.44μg/L(P<0.001), there is no significant difference Between Patients with CRBSI and without CRBSI in the level of white blood cells and C-reactive protein. Conclusions: PCT was a valuable early diagnostic parameter for CRBSI.

Key words: Procalcitonin, Hemodialysis, Catheter-related bloodstream infection

中图分类号: